Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion.

Mendes-Braz M, Elias-Miró M, Kleuser B, Fayyaz S, Jiménez-Castro MB, Massip-Salcedo M, Gracia-Sancho J, Ramalho FS, Rodes J, Peralta C.

Liver Int. 2014 Aug;34(7):e271-89. doi: 10.1111/liv.12348.

PMID:
24107124
2.

Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion.

Elias-Miró M, Mendes-Braz M, Cereijo R, Villarroya F, Jiménez-Castro MB, Gracia-Sancho J, Guixé-Muntet S, Massip-Salcedo M, Domingo JC, Bermudo R, Rodés J, Peralta C.

J Hepatol. 2014 Jan;60(1):87-95. doi: 10.1016/j.jhep.2013.07.041.

PMID:
23968888
3.

Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion.

Elias-Miró M, Massip-Salcedo M, Raila J, Schweigert F, Mendes-Braz M, Ramalho F, Jiménez-Castro MB, Casillas-Ramírez A, Bermudo R, Rimola A, Rodes J, Peralta C.

Liver Transpl. 2012 Oct;18(10):1198-208. doi: 10.1002/lt.23489.

4.

Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?

Ramalho FS, Alfany-Fernandez I, Casillas-Ramirez A, Massip-Salcedo M, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.

J Pharmacol Exp Ther. 2009 Apr;329(1):130-40. doi: 10.1124/jpet.108.147835.

5.

Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion.

Ben Mosbah I, Alfany-Fernández I, Martel C, Zaouali MA, Bintanel-Morcillo M, Rimola A, Rodés J, Brenner C, Roselló-Catafau J, Peralta C.

Cell Death Dis. 2010 Jul 8;1:e52. doi: 10.1038/cddis.2010.29.

6.
7.

Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion.

Massip-Salcedo M, Zaouali MA, Padrissa-Altés S, Casillas-Ramirez A, Rodés J, Roselló-Catafau J, Peralta C.

Hepatology. 2008 Feb;47(2):461-72.

PMID:
18098300
8.

Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids.

Marsman HA, de Graaf W, Heger M, van Golen RF, Ten Kate FJ, Bennink R, van Gulik TM.

Br J Surg. 2013 Apr;100(5):674-83. doi: 10.1002/bjs.9059.

PMID:
23456631
9.

Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.

Ben Mosbah I, Roselló-Catafau J, Alfany-Fernandez I, Rimola A, Parellada PP, Mitjavila MT, Lojek A, Ben Abdennebi H, Boillot O, Rodés J, Peralta C.

Liver Transpl. 2010 Feb;16(2):163-71. doi: 10.1002/lt.21968.

10.

Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury.

Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M, Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C.

Crit Care Med. 2008 Apr;36(4):1256-66. doi: 10.1097/CCM.0b013e31816a023c.

PMID:
18379253
11.

Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.

Steenks M, van Baal MC, Nieuwenhuijs VB, de Bruijn MT, Schiesser M, Teo MH, Callahan T, Padbury RT, Barritt GJ.

HPB (Oxford). 2010 May;12(4):250-61. doi: 10.1111/j.1477-2574.2010.00160.x.

12.

Effect of ischaemic preconditioning on hepatic oxygenation, microcirculation and function in a rat model of moderate hepatic steatosis.

Koti RS, Yang W, Glantzounis G, Quaglia A, Davidson BR, Seifalian AM.

Clin Sci (Lond). 2005 Jan;108(1):55-63.

PMID:
15341510
13.

Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism.

Selzner N, Selzner M, Jochum W, Clavien PA.

J Hepatol. 2003 Jul;39(1):55-61.

PMID:
12821044
14.

Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Abshagen K, Mertens F, Eipel C, Vollmar B.

Int J Clin Exp Pathol. 2013 Aug 15;6(9):1759-69.

15.

The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.

Nakano H, Nagasaki H, Barama A, Boudjema K, Jaeck D, Kumada K, Tatsuno M, Baek Y, Kitamura N, Suzuki T, Yamaguchi M.

Hepatology. 1997 Sep;26(3):670-8.

PMID:
9303498
16.

Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats.

Marsman HA, Heger M, Kloek JJ, Nienhuis SL, ten Kate FJ, van Gulik TM.

Dig Liver Dis. 2011 Dec;43(12):984-90. doi: 10.1016/j.dld.2011.07.009.

PMID:
21840275
17.
18.

Fatty liver in liver transplantation and surgery.

Selzner M, Clavien PA.

Semin Liver Dis. 2001;21(1):105-13. Review.

PMID:
11296690
19.

Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver.

Kuroda S, Tashiro H, Igarashi Y, Tanimoto Y, Nambu J, Oshita A, Kobayashi T, Amano H, Tanaka Y, Ohdan H.

J Hepatol. 2012 Jan;56(1):146-52. doi: 10.1016/j.jhep.2011.04.029.

PMID:
21756846
20.

A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.

He S, Atkinson C, Evans Z, Ellett JD, Southwood M, Elvington A, Chavin KD, Tomlinson S.

J Immunol. 2009 Oct 1;183(7):4764-72. doi: 10.4049/jimmunol.0900550.

Supplemental Content

Support Center